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INTRODUCTION
Ewing sarcoma (EWS) is the second most common
primary malignant bone tumor.1 It is characterized by
small round cells with basophilic nuclei, scanty
cytoplasm, and brisk mitotic activity. Rearrangements of
the EWSR1 (Ewing sarcoma breakpoint region 1) gene
on the 22q12 and related oncogenes, most commonly
FLI1 on 11q24, are detected in about 90 to 95% of these
tumors.2
Neural/neuroectodermal differentiation may be seen in
EWS/PNET which is histologically evident as rosette-like
structures, and/or ganglionic differentiation. These
structures demonstrate variable immunoreactivity for
neural markers, such as neuron specific enolose (NSE),
CD57, S100 protein, synaptophysin, and PGP9.5.3 This
suggests a link between EWS/PNETs and neuro-
blastomas (NB). Cytogenetically, neuroblastomas do not
show (11;22) translocation or its variants. They are
rather, characterized at a cytogenetic-molecular level by
deletion or rearrangement of the short arm of
chromosome 1, amplification of N-MYC (neuroblastoma-
derived myelocytomatosis oncogene), and gain of
chromosome 17q1p.4 Histologically, NBs show a broad
spectrum of differentiation, ranging from undifferentiated
tumors composed only of small round cells without
neuroblasts or neuropil formation, to the most
differentiated tumors showing partial or complete
ganglionic differentiation. Unlike EWS/PNET, NBS do
not express CD99.4
Post-therapy neural differentiation of the EWS/PNET is
a very rare event and to the best of our knowledge, only
4 cases have been reported in literature, all in females
below 20 years of age.2,5-7 Here, we present to our best
of knowledge, the first case of post-therapy NB-like
differentiation in a male patient of 21-years.
CASE REPORT
A 21-year male presented with a history of fracture of the
right humerus following minor trauma during a sports
activity. A bone scan was performed two months after
the initial presentation and it demonstrated increased
uptake at the right shoulder joint, distal two-thirds of the
shaft of right humerus and adjacent proximal end of right
radius. There was no evidence of distant skeletal
metastases. MRI showed an abnormal heterogenous
mixed signal destructive lesion measuring 15x6.1x5cm
with a soft tissue component and surrounding bone
edema at humeral diaphysis extending down to the
metaphysis with sparing of epiphysis. A biopsy of the
bone was taken at the same time which showed a small
round blue cell tumor (Figure 1A) exhibiting cytoplasmic
glycogen on PAS stain and strong membranous staining
for immunohistochemical stain CD99. Leucocyte
common antigen (LCA), TdT, desmin, and synaptophysin
were negative. It was reported as EWS, based on
morphological and immunohistochemical features.
CT scan of the abdomen/pelvis was normal. However,
CT scan of the lungs revealed a small nodule in the
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posterior basal segment of the lower lobe of the left lung,
raising suspicion of possible metastases.
Chemotherapy was started and 5 cycles of VAC/IE
(Vincristine, Actinomycin D, Cyclophosphamide/
Ifosfamide, Etoposide) were given over a period of 6
months. MRI of the right arm, performed after 4 cycles of
chemotherapy, showed a slight reduction of tumor size
which now measured 13x6.1x5cm. There was a
significant reduction in the swelling, but the hard
component remained the same. The patient was
admitted for an elective right humerus wide margin
resection plus a vascularized fibular graft and flap
surgery.
The excised specimen comprised of a segment of
humerus with attached fibromuscular tissue and small
ellipse of skin with previous biopsy scar. The specimen
measured 17x9x6.5cm. Sectioning revealed a grey
white solid tumor measuring 6x5cm. Representative
sections from tumor along with bone and soft tissue
margins were taken.
Histopathological examination revealed a biphasic
tumor. There were sheets of small round blue cells
containing hyperchromatic nuclei and scant cytoplasm.
Mitotic figures were readily identified. Scattered in
between were discrete relatively hypocellular areas
composed of small round cells in a neuropil background
(Figures 1B and 1C). Few ganglion cells were seen
suggesting neuroblastic differentiation (Figure 1D).
Immunohistochemical stain synaptophysin was positive
in neuroblastomatous areas (Figure 2A), while neuro-
filament was negative. CD99 was positive in EWS areas
(Figures 2B and 2C). Based on morphological and
immunohistochemical features, a diagnosis of Ewing
sarcoma/PNET with post-chemotherapy NB-like
differentiation was rendered. Cytogenetic analysis of the
post-chemotherapy specimen by Fluorescence in situ
Hybridization (FISH) showed EWSR1 gene rearrangement
(Figure 2D).
Postoperative bone scan and CT scan of lung showed
no metastatic involvement. The postoperative chemo-
therapy regimen included adjunct therapy with VAC/IE
and a total of 7 cycles were given post-operatively. The
last cycle was given 6 months after surgery. The patient
passed away, exactly 12 months after the initiation of
treatment.
DISCUSSION
EWS/PNET may rarely exhibit evidence of complete
neuronal differentiation. Such differentiation has been
shown to occur spontaneously in EWS/PNETs at some
peculiar sites such as cauda equina,8 or it may become
evident after treatment.2,5-7 All cases of post-
chemotherapy NB-like differentiation reported so far
occurred in females between 10 to 17 years of age
(mean 12.5 years).2,5-7 Our case is the first to be
reported in a male patient. Of the previous reported
cases, two tumors were located in the bone (radius and
iliac bone),5,7 while two were extraskeletal (forearm and
retroperitoneum).2,6 The size of tumors ranged from 4 to
14 cms (mean 11 cms).2,5-7 The follow-up of the reported
cases ranged from 2 to 30 months (mean follow-up,
14 months).2,5-7 One patient died of disease due to lung
metastasis,5 while the other 3 were alive at last follow-
up.2,6,7 Our patient died of disease 12 months after
surgery.
It is believed that neuronal differentiation occurs in EWS
patients as a result of chemotherapy.2,5-7 The reason
why chemotherapy sometimes leads to neuronal
differentiation in EWS/PNET is still unclear. There is no
set trend in the chemotherapy regimen or time period
until surgery in the reported patients, which could be
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Figure 1: Pretreatment biopsy composed of sheets of round blue cells
(A, H&E, 100x magnification). Posttreatment biopsy showed sheets of round
blue cell with interspersed discrete hypocellular nodules in a background of
neuropil (B,C; 40 & 100x magnification). Ganglionic differentiation in discrete
nodules (D, H&E, 400x magnification).
Figure 2: Synaptophysin positivity in nodules of neuroblastmatous
differentiation (A). CD99 positivity in Ewing sarcoma areas with sparing of
neuroblastomatous nodules (B,C). FISH for EWSR1 showed EWSR1 gene
rearrangement indicated by separate green and red signals (D).
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cited as a probable common causative factor in the
reported cases, as different regimens were given to
these patients.2,5-7
All reported cases, before this one, show only one
consistent trend: female gender. However, the number
of reported cases is very small and there is no sufficient
data to conclude that gender difference plays any role in
causing neuronal differentiation following chemotherapy
in patients with EWS. The possibility that neural
differentiation is independent of chemotherapy cannot
be entirely excluded. Recently, Vali et al. reported the
presence of NB-like differentiation in an extraskeletal
retroperitoneal EWS/PNET in the absence of any
chemotherapy.9 They hypothesized that additional
genetic or epigenetic modifications may lead to the
creation of a separate clone of NB-like malignant cells
within the primary mass of some EWS/PNETs.9
The effect of neural differentiation on the prognosis of
EWS/PNET is not known due to the scarcity of data
available. It is possible that if more cases are reported,
a new therapy regimen might be devised for the
treatment of such mixed tumors. In summary, we report
another example of this rare histologic change in
EWS/PNET following chemotherapy highlighting the
necessity of ancillary and molecular studies.
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